Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 79929-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 79929-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot presenting effect estimates (odds ratios or risk ratios) with confidence intervals from various contraceptive studies between 2002 and 2017. The studies include NICHD, French E3N cohort, Shangai Women's Health, Nurses' Health, Oxford Family Planning, and Danish Sex Hormone Register, comparing ever use and current use of contraceptives. The effect estimates range approximately from 0.9 to 1.3.*
FDA Label Image

Ethinyl Estradiol Chemical Structure (Levo Ee Ee Structure)

Ethinyl Estradiol Chemical Structure (Levo Ee Ee Structure)
Chemical structure diagram of Ethinyl Estradiol, showing its molecular formula C20H24O2 and molecular weight 296.4. The diagram displays the steroid framework with characteristic hydroxyl (OH) and ethynyl (C≡CH) groups.*
FDA Label Image

Figure 1 (Levo Ee Fig1)

Figure 1 (Levo Ee Fig1)
A horizontal bar chart showing the number of women with a blood clot out of 10,000 women years (WY) for different groups: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) (range 40 to 65). A footnote indicates pregnancy data is based on actual duration in reference studies with an assumption of nine months' duration.*
FDA Label Image

Levonorgestrel And Ethinyl Estradiol Tablets-carton (Levo Ee Fig2)

Levonorgestrel And Ethinyl Estradiol Tablets-carton (Levo Ee Fig2)
Chart illustrating the rate of pregnancies per 100 women in one year based on different birth control methods. Methods with fewer pregnancies include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones. Methods with more pregnancies include condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*
FDA Label Image

Fig-3 (Levo Ee Fig3)

Fig-3 (Levo Ee Fig3)
Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg kit label by Naari Pte Ltd, containing 28 tablets. The label includes a weekly dosing calendar with circles for each day of the week across four weeks, space for lot and expiration dates, and storage instructions to keep at 20°C to 25°C (68°F to 77°F). Made in India.*
FDA Label Image

Levonorgestrel Chemical Structure (Levo Ee Levo Structure)

Levonorgestrel Chemical Structure (Levo Ee Levo Structure)
Chemical structure of Levonorgestrel shown as a steroid backbone with specific chemical groups, labeled with its molecular formula C21H28O2 and molecular weight 312.4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.